|
181 |
Soluble lymphocyte activation gene-3 (sLAG3) and CD4/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies
Enthalten in British journal of cancer Bd. 130, 17.1.2024, Nr. 6, date:4.2024: 1013-1022
|
|
|
|
182 |
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study
Enthalten in Annals of hematology Bd. 102, 18.8.2023, Nr. 10, date:10.2023: 2741-2752
|
|
|
|
183 |
Telomere length dynamics measured by flow-FISH in patients with obesity undergoing bariatric surgery
Enthalten in Scientific reports Bd. 13, 6.1.2023, Nr. 1, date:12.2023: 1-8
|
|
|
|
184 |
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib
Enthalten in Leukemia Bd. 38, 21.12.2023, Nr. 2, date:2.2024: 318-325
|
|
|
|
185 |
Towards personalized medicine with iPS cell technology: a case report of advanced systemic mastocytosis with associated eosinophilia
Enthalten in Annals of hematology Bd. 101, 20.9.2022, Nr. 11, date:11.2022: 2533-2536
|
|
|
|
186 |
Transient elastography in adult patients with cryptic dyskeratosis congenita reveals subclinical liver fibrosis: a retrospective analysis of the Aachen telomere biology disease registry
Enthalten in Orphanet journal of rare diseases Bd. 16, 26.9.2021, Nr. 1, date:12.2021: 1-7
|
|
Administration
